Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Journal
Overview
publication venue for
Introduction to History, Culture, and Liver Disease series.
2024
The trials, tribulations, and triumph of Ulysses S. Grant with alcohol.
2024
A tale of two diseases: ALD and MASLD requirements and monitoring for liver transplantation.
2024
Evolution of the transplant hepatology fellowship application process and its impact on the future of the hepatology workforce.
2024
Financial burden following adult liver transplantation is common and associated with adverse recipient outcomes.
2024
Advancing our standards: Do we need to standardize the use of Non-Standard donor organ in Low-MELD patients?
2024
Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals.
2023
Management of patients with cirrhosis in the emergency department: Implications for hospitalization outcomes.
2023
Disparities in travel time to liver transplantation centers in the United States.
2023
Affordable care act medicaid expansion associated with increased liver transplant waitlist access without worsening mortality.
2023
National survey of second opinions for hospitalized patients in need of liver transplantation.
2023
CAQ Corner: Evaluation and management of living liver donors.
2023
Ethnic disparities in waitlist outcomes of patients with nonalcoholic steatohepatitis listed for liver transplantation in the US. .
29.
2023
Evaluation and management of the living donor recipient.
2023
Infections in liver transplant recipients.
2023
CT-quantified sarcopenic visceral obesity is associated with poor transplant waitlist mortality in patients with cirrhosis.
2023
Practice Patterns of the Medical Evaluation of Living Liver Donors in the United States.
2022
Black patients and women have reduced access to liver transplantation for alcohol-associated liver disease.
2022
Deceased donor liver transplantation in patients on direct oral anticoagulants at the time of transplant surgery: A case series.
2022
Practices and Perceptions Living Donor Liver Transplant, Non-Directed Donation, and Liver Paired Exchange: A National Survey.
2021
Medicaid Expansion Association With End-Stage Liver Disease Mortality Depends on Leniency of Medicaid Hepatitis C Virus Coverage.
2021
The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With Alcohol-Associated Hepatitis.
2021
National Trends in Location of Death in Patients With End-Stage Liver Disease. .
27.
2021
The North American Consortium for the Study of End-Stage Liver Disease-Acute-on-Chronic Liver Failure Score Accurately Predicts Survival: An External Validation Using a National Cohort. .
26.
2020
Patient Perspectives of High-Quality Care on the Liver Transplant Waiting List: A Qualitative Study. .
26.
2019
Profiling Gene Programs in the Blood During Liver Regeneration in Living Liver Donors. .
25.
2019
Sorafenib in Hepatopulmonary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. .
25.
2019
Liver paired exchange: Can the liver emulate the kidney? .
24.
2018
Liver atrophy and regeneration in noncirrhotic portal vein thrombosis: Effect of surgical shunts. .
24.
2018
Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience. .
23.
2017
Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma. .
23.
2017
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection. .
22.
2016
Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients. .
22.
2016
Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network. .
22.
2016
Fully laparoscopic left-sided donor hepatectomy is safe and associated with shorter hospital stay and earlier return to work: A comparative study. .
21.
2015
Changes in liver and spleen volumes after living liver donation: a report from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL). .
21.
2015
Liver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms. .
20.
2014
The impact of left ventricular hypertrophy on survival in candidates for liver transplantation. .
20.
2014
Bland embolization versus chemoembolization of hepatocellular carcinoma before transplantation. .
20.
2014
Combined lung and liver transplantation: analysis of a single-center experience. .
20.
2013
Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues. .
19.
2013
Segment 4 architecture and proposed parenchyma-wise technique for Ex vivo graft procurement and implantation. .
19.
2013
Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium. .
19.
2013
Cholestatic hepatitis C following liver transplantation: an outcome-based histological definition, clinical predictors, and prognosis. .
19.
2013
Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis. .
18.
2012
Prevention of de novo hepatitis B with adefovir dipivoxil in recipients of liver grafts from hepatitis B core antibody-positive donors. .
18.
2012
Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C. .
18.
2012
Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study. .
18.
2012
Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus. .
18.
2012
Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus. .
17.
2011
Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. .
17.
2011
Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple model for end-stage liver disease-independent prognostic factors. .
16.
2010
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. .
16.
2010
Health-related quality of life and survival in liver transplant candidates. .
16.
2010
Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation. .
14.
2008
Utility of liver allograft biopsy obtained at procurement. .
14.
2008
Isolation and characterization of a novel population of progenitor cells from unmanipulated rat liver. .
14.
2008
Employment and quality of life in liver transplant recipients. .
13.
2007
Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C. .
13.
2007
Postresection hepatic failure: successful treatment with liver transplantation. .
13.
2007
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. .
13.
2007
Portocaval hemitransposition in pediatric liver transplant recipients: a single-center experience. .
12.
2006
Preoperative characteristics and intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scores. .
12.
2006
Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease. .
12.
2006
Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. .
11.
2005
MELD fails to measure quality of life in liver transplant candidates. .
11.
2005
Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. .
10.
2004
One-year morbidity after donor right hepatectomy. .
10.
2004
Outcomes of acute rejection after interferon therapy in liver transplant recipients. .
10.
2004
A model to predict the development of mental status changes of unclear cause after liver transplantation. .
9.
2003
Scope of worldwide hepatitis C problem. .
9.
2003
Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors. .
9.
2003
Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation. .
9.
2003
Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. .
9.
2003
Acquired hemophilia A after liver transplantation: a case report. .
9.
2003
MELD score predicts 1-year patient survival post-orthotopic liver transplantation. .
9.
2003
Clinical and ethnic differences in candidates listed for liver transplantation with and without potential living donors. .
9.
2003
Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation. .
9.
2003
Donor and recipient outcomes in right lobe adult living donor liver transplantation. .
8.
2002
Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome. .
8.
2002
Is it cost-effective to treat recurrent hepatitis C infection in orthotopic liver transplantation patients? .
8.
2002
Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. .
8.
2002
Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt. .
8.
2002
Technical and logistical considerations of in situ split-liver transplantation for two adults: Part II. Creation of left segment I-IV and right segment V-VIII grafts. .
8.
2002
Technical and logistical considerations of in situ split-liver transplantation for two adults: Part I. Creation of left segment II, III, IV and right segment I, V-VIII grafts. .
7.
2001
Pneumocystis carinii pneumonia prophylaxis with atovaquone in trimethoprim-sulfamethoxazole-intolerant orthotopic liver transplant patients: a preliminary study. .
7.
2001
Technical challenges of hepatic venous outflow reconstruction in right lobe adult living donor liver transplantation. .
7.
2001
An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. .
6.
2000
Endoscopic management of biliary leaks after T-tube removal in liver transplant recipients: nasobiliary drainage versus biliary stenting. .
6.
2000
Reply. .
27.
2021
Whose Liver Is It Anyway? Two Centers Participating in One Living Donor Transplantation. .
25.
2019
Reply: To PMID 23840026. .
20.
2014
Prevention of de novo hepatitis B with adefovir plus vaccination in recipients of liver transplants from core antibody-positive donors. .
19.
2013
Intrahepatic recurrence of hepatocellular carcinoma 13 years after orthotopic liver transplantation for hepatitis C-related cirrhosis with occult hepatocellular carcinoma: a case report. .
18.
2012
Is the cost of adult living donor liver transplantation higher than deceased donor liver transplantation? .
10.
2004
Changes in Liver Transplant Center Practice in Response to Coronavirus Disease 2019: Unmasking Dramatic Center-Level Variability.
2020
Pregnancy in Liver Transplantation.
2020
Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA.
2004
Low-dose aspirin, rejection, and thrombosis: Is it the Wonder Drug® of liver transplantation?
2022
Caring for a child after a liver transplant: Challenges beyond medical complexity. .
28.
2022
Introducing the Certificate of Added Qualification (CAQ) Corner.
2022
Achieving Equity for Liver Transplant Recipients with Chronic Kidney Disease.
2022
The Dark Before Dawn.
2022
A New Hope for a New Year.
2021
Protecting Patients with Cirrhosis from COVID-19: Identifying Gaps in Vaccination Rates.
2021
Social Media Editors: Tweeters With a Cause.
2021
A New Year, A New Team. .
27.
2020
Living Donor Liver Transplant: Send in the Robots. .
26.
2020
Improving Perioperative Cardiac Risk Stratification in Liver Transplant: A New Role for Coronary Computed Tomography Angiography? .
26.
2020
Identifying Risk of Alcohol Relapse After Liver Transplantation: What Tools Do We Need? .
25.
2019
Drivers of the cost of liver transplantation: is it the donor, the recipient, or the center? .
15.
2009
Is recurrence of hepatitis C worse after living donor or deceased donor liver transplantation? .
10.
2004
The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin.
2021
Can Living Donor Liver Transplantation in the United States Reach Its Potential?
2021
A Review of the Current State of Liver Transplantation Disparities.
2021
Role of Terlipressin and Albumin for Hepatorenal Syndrome in Liver Transplantation.
2020
Critical care issues in patients after liver transplantation.
2011
Transplantation-mediated alloimmune thrombocytopenia: Guidelines for utilization of thrombocytopenic donors.
2008
Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature.
2001
Coagulopathy and hemostasis management in patients undergoing liver transplantation: Defining a dynamic spectrum across phases of care.
2022
A Diagnostic Test Meta-Analysis Evaluating Imaging-Based and Blood Biomarker-Based Assessment Tools for Fibrosis After Liver Transplantation.
2021
A Meta-Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients.
2021
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)
